Y. Lis

1.3k total citations · 1 hit paper
16 papers, 991 citations indexed

About

Y. Lis is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Surgery. According to data from OpenAlex, Y. Lis has authored 16 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 4 papers in Economics and Econometrics and 2 papers in Surgery. Recurrent topics in Y. Lis's work include Pharmaceutical Economics and Policy (3 papers), Iron Metabolism and Disorders (2 papers) and Heart Failure Treatment and Management (2 papers). Y. Lis is often cited by papers focused on Pharmaceutical Economics and Policy (3 papers), Iron Metabolism and Disorders (2 papers) and Heart Failure Treatment and Management (2 papers). Y. Lis collaborates with scholars based in United Kingdom, United States and Canada. Y. Lis's co-authors include SR Walker, Dennis W. Raisch, Jeff J. Guo, Boyang Bian, John Doyle, Roderick A.F. MacLeod, Wilhelm G. Dirks, Hans G. Drexler, E. Becker and Roger Williams and has published in prestigious journals such as Biochemical Journal, Biochemical and Biophysical Research Communications and Journal of Clinical Epidemiology.

In The Last Decade

Y. Lis

16 papers receiving 919 citations

Hit Papers

Pharmaceutical innovation by the seven UK‐owned pharmaceu... 1988 2026 2000 2013 1988 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pharmaceutical innovation by the seven UK‐owned pharmaceutical companies (1964‐1985).
    1988 338 citations Y. Lis, SR Walker et al. British Journal of Clinical Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. Lis United Kingdom 12 183 166 141 134 128 16 991
L.F. Lacey United Kingdom 19 223 1.2× 164 1.0× 74 0.5× 99 0.7× 34 0.3× 36 1.5k
Tomas Salmonson Sweden 27 449 2.5× 304 1.8× 284 2.0× 121 0.9× 57 0.4× 60 1.7k
John Duan United States 12 272 1.5× 297 1.8× 68 0.5× 134 1.0× 75 0.6× 23 1.2k
Huang Sm United States 12 208 1.1× 329 2.0× 59 0.4× 359 2.7× 69 0.5× 26 1.1k
Satjit Brar United States 10 158 0.9× 282 1.7× 60 0.4× 198 1.5× 66 0.5× 15 838
Brian N. Swanson United States 22 458 2.5× 82 0.5× 59 0.4× 123 0.9× 58 0.5× 64 3.4k
Megan Gibbs United States 21 313 1.7× 300 1.8× 65 0.5× 378 2.8× 103 0.8× 46 1.3k
Vijay Upreti United States 20 403 2.2× 491 3.0× 41 0.3× 328 2.4× 79 0.6× 55 1.7k
Bruce K. Birmingham United States 13 66 0.4× 258 1.6× 122 0.9× 189 1.4× 81 0.6× 23 933
S. Thomas Forgue United States 16 181 1.0× 130 0.8× 20 0.1× 99 0.7× 38 0.3× 28 1.2k

Countries citing papers authored by Y. Lis

Since Specialization
Citations

This map shows the geographic impact of Y. Lis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Lis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Lis more than expected).

Fields of papers citing papers by Y. Lis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Lis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Lis. The network helps show where Y. Lis may publish in the future.

Co-authorship network of co-authors of Y. Lis

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Lis. A scholar is included among the top collaborators of Y. Lis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Lis. Y. Lis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Cock, E De, Amin Haiderali, Radoslaw Wasiak, Y. Lis, & Vincent Lévy. (2011). PCN120 The Natural History of Fludarabine-Refractory Chronic Lymphocytic Leukemia Patients Who Fail Alemtuzumab or Have Bulky Lymphadenopathy – A European Perspective. Value in Health. 14(7). A456–A456. 1 indexed citations
3.
4.
Walker, Mel, et al.. (2006). The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databases. Current Medical Research and Opinion. 22(7). 1249–1256. 54 indexed citations
5.
Dirks, Wilhelm G., et al.. (2002). Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines. International Journal of Cancer. 100(1). 49–56. 103 indexed citations
6.
Lis, Y.. (1995). The VAMP research multi-purpose database in the U.K.. Journal of Clinical Epidemiology. 48(3). 431–443. 109 indexed citations
7.
Hall, Gillian C., et al.. (1993). Micturin (Terodiline Hydrochloride), Torsades de Pointe and other Arrhythmias — A Study using the VAMP Database. Pharmacoepidemiology and Drug Safety. 2(2). 127–132. 3 indexed citations
8.
Lis, Y., Walter O. Spitzer, Ronald D. Mann, et al.. (1993). A concurrent cohort study of oral contraceptive users from the VAMP research bank. Pharmacoepidemiology and Drug Safety. 2(1). 51–63. 16 indexed citations
9.
Lis, Y. & SR Walker. (1989). Novel medicines marketed in the UK (1960‐87).. British Journal of Clinical Pharmacology. 28(3). 333–343. 11 indexed citations
10.
Lis, Y., et al.. (1988). Pharmaceutical innovation by the seven UK‐owned pharmaceutical companies (1964‐1985).. British Journal of Clinical Pharmacology. 25(3). 387–396. 338 indexed citations breakdown →
11.
12.
Lis, Y., et al.. (1987). Biochemical characterization of individual normal, floppy and rheumatic human mitral valves. Biochemical Journal. 244(3). 597–603. 62 indexed citations
13.
Lis, Y., Deborah H. Bennett, George H. Lambert, & D. Robson. (1984). A preliminary double-blind study of intravenous nitroglycerin in acute myocardial infarction. Intensive Care Medicine. 10(4). 179–184. 49 indexed citations
14.
Bomford, Adrian, Marc Berger, Y. Lis, & Roger Williams. (1978). The iron content of human liver and spleen isoferritins correlates with their isoelectric point and subunit composition. Biochemical and Biophysical Research Communications. 83(1). 334–341. 33 indexed citations
15.
Bomford, Adrian, Y. Lis, I G McFarlane, & Roger Williams. (1977). Variation in the distribution of two human heart ferritin species. Isoferritin profile and subunit composition in normal and iron-overloaded subjects. Biochemical Journal. 167(1). 309–312. 25 indexed citations
16.
Bennett, Ed, N H Brooks, J R Keddie, Y. Lis, & Ana Wilson. (1977). Increased Renal Function in Patients with Acute Left Ventricular Failure: A Possible Homeostatic Mechanism. Clinical Science. 52(1). 43–50. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L.F. Lacey Breakdown of academic impact, for papers by Tomas Salmonson Breakdown of academic impact, for papers by John Duan Breakdown of academic impact, for papers by Huang Sm Breakdown of academic impact, for papers by Satjit Brar Breakdown of academic impact, for papers by Brian N. Swanson Breakdown of academic impact, for papers by Megan Gibbs Breakdown of academic impact, for papers by Vijay Upreti Breakdown of academic impact, for papers by Bruce K. Birmingham Breakdown of academic impact, for papers by S. Thomas Forgue
Rankless by CCL
2026